leadf
logo-loader
viewBraxia Scientific Corp.
(
CSE:BRAXOTC:BRAXFFRA:496
)

Champignon Brands receives DTC eligibility for easier US trading

The Vancouver-based company is 'actively engaged' in pursuing new avenues of distribution both in North America and internationally

Champignon Brands Inc. -
The DTC, or Depository Trust Company, allows Champignon’s shares to be eligible for electronic clearing and settlement

Champignon Brands Inc (CSE:SHRM) (OTCMKTS:SHRMF) announced Friday that it had received DTC eligibility to simplify the process of trading and transferring shares in the US.

The DTC, or Depository Trust Company, allows Champignon’s shares to be eligible for electronic clearing and settlement.

“We are actively engaged in pursuing new avenues of distribution both in North America and internationally, in order to enhance the ability of larger audiences to participate in the Champignon story, as well as broaden our already robust shareholder base,” said Gareth Birdsall, Champignon’s CEO.

READ: Champignon Brands inks blockbuster deal to roll out network of psychedelic medicine clinics in North America

“With the receipt of DTC eligibility, our common shares will become accessible to United States investors, both retail and institutional - the jurisdiction where many of the important initiatives in psychedelic medicine are emanating and where the company plans to roll out new clinical entities within significant urban population centres."

The Vancouver-based company is positioning itself as a leader in the burgeoning psychedelics space. It is planning to roll out five unique ketamine clinics across Florida, California and the US Eastern Seaboard, with additional ketamine clinics projected to be fully operational by the fourth quarter of 2020.

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

Quick facts: Braxia Scientific Corp.

Follow
CSE:BRAX

Price: 0.19 CAD

Market Cap: $31.99 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Braxia Scientific partners with Neurotherapy to open first Ketamine clinic...

Braxia Scientific (CSE: BRAX – OTCQB: SHRMF) CEO Roger McIntyre joined Steve Darling from Proactive to bring news the company is working with Neurotherapy Montreal tp open a state of the art 14,000 square foot facility providing leading mental health and rehabilitation services using novel...

on 05/13/2021

2 min read